Issue de la troncature de la dextrane-saccharase DSR-E, l’alpha-(1→2) transglucosidase recombinante GBD-CD2 catalyse à partir de saccharose le branchement de molécules acceptrices tels que les dextranes, les isomalto-oligosaccharides ou les gluco-oligosaccharides (GOS ; [6)-alpha-D-Glcp-(1→]n-alpha-D-Glcp-(1→4)-D-Glcp, avec 1<n<9). L’objet de cette étude a porté sur la compréhension des relations structure-activité de GBD-CD2 afin d’investiguer les facteurs structuraux responsables de la synthèse des liaisons osidiques de type alpha-(1→2). La troncature rationnelle du domaine de liaison au glucane (GBD) de l’enzyme GBD-CD2 (192 kDa) a abouti à l’isolement de trois formes tronquées actives, de masses moléculaires égales à 180, 147 et 123 kDa. Après purification de GBD-CD2 et de delta N123-GBD-CD2 (123 kDa), des études cinétiques ont permis de mettre en évidence que les enzymes présentent la même régiospécificité. L’activité d’hydrolyse du saccharose peut être modélisée par le modèle de Michaelis – Menten (kcat respectifs de 109 et 76 s-1). En présence de dextrane accepteur, ces enzymes sont activées. L’activité d’alpha-(1→2) glucosylation suit un modèle Ping Pong Bi Bi (kcat respectifs de 970 et 947 s-1). En modulant le ratio molaire entre le donneur d’unités glucosyle et l’accepteur de ces unités ([saccharose]/[dextrane]), il est possible de synthétiser des dextranes dont le pourcentage de liaisons alpha-(1→2) est contrôlé et varie de 10% à 40%. La caractérisation des produits de la réaction menée en présence de saccharose et de GOS a permis d’isoler et de caractériser pour la première fois des GOS arborant des unités glucosyle branchées en alpha-(1→2) sur les unités glucosyle adjacentes de la chaîne principale. Enfin, la résolution de la structure de delta N123-GBD-CD2 à 3,2 Å révèle que cette enzyme adopte le repliement original « en U » similaire à celui décrit pour GTF180-delta N. La comparaison des gorges catalytiques des deux dextrane-saccharases cristallisées apporte des éléments pouvant expliquer la régiospécificité singulière de delta N123-GBD-CD2, et ouvre la voie à des travaux de mutagenèse visant à investiguer le rôle de résidus potentiellement clés / GBD-CD2 is a recombinant alpha-(1→2) transglucosidase constructed by truncation of the DSR-E dextransucrase from Leuconostoc mesenteroides NRRL B-1299. From sucrose, GBD-CD2 catalyses the alpha-(1→2) branching reaction onto acceptor molecules such as dextrans, isomalto-oligosaccharides or gluco-oligosaccharides (GOS; [6)-alpha-D-Glcp-(1→]n-alpha-D-Glcp-(1→4)-D-Glcp, 1<n<9). This work has been focused on structure activity relationship studies. Rational truncations of the glucan binding domain (GBD) led to the expression in E. coli of three active enzymes, showing molecular masses of 180, 147 and 123 kDa. After purification of the recombinant GBD-CD2 and delta N123-GBD-CD2, we showed that both enzymes display the same regiospecificity. Steady-state kinetics revealed that the activity of sucrose hydrolysis displays a Michaelis Menten type of kinetics (kcat 109 s-1 and 76 s-1, respectively). In the presence of dextran acceptor, these enzymes are activated. The alpha-(1→2) transglucosidase activity from sucrose onto dextrans was modelled by a Ping Pong Bi Bi mechanism (kcat 970 s-1 and 947 s-1, respectively). When varying the molar ratio between the glucosyl donor and the acceptor ([sucrose]/[dextran]), the percentage of alpha-(1→2) linkages in dextrans can be controlled from 10% to 40%. Additionally, from reactions in the presence of GOS and sucrose, we isolated and characterized new alpha-(1→2) branched GOS with contiguous alpha-(1→2) branchings along linear GOS chains. Finally, the X-ray structure of delta N123-GBD-CD2 at 3.2 Å resolution revealed that this enzyme has a very original “U folding” similar to that described for GTF180-delta N. Study of the residues lining the catalytic gorges of the two crystallized enzymes revealed the structural determinants possibly involved in the singular regiospecificity of delta N123-GBD-CD2. Our work opens the way to mutagenesis work for discovering key structural determinants of delta N123-GBD-CD2

Orientador: Flávio Ruas de Moraes / Banca: Luiz Edivaldo Pezzato / Banca: Newton Castagnolli / Banca: Laura Satiko Okada Nakaghi / Banca: Sérgio Henrique Canello Schalch / Resumo: o objetivo deste estudo foi avaliar a aplicabilidade do modelo de crescimento exponencial no estudo da eficiência da suplementação alimentar com mananoligossacarídeo e 'beta'-glucano para tilápias do Nilo criadas em tanques-rede. O experimento foi realizado em piscicultura de criação de tilápias em tanques-rede, no município de Zacarias, SP. Foram utilizadas tilápias jovens, com peso inicial de 25,4 ± 2,04 g, distribuídas em 12 tanques-rede de 2 x 2 x 1,5 m, com volume útil de 6 m3 e densidade de 2500 peixes por tanque. Para estudo das curvas de crescimento, realizou-se a biometria individual de uma amostra aleatória de 5 % dos peixes de cada unidade experimental. Os resultados do presente estudo permitem concluir que a adição de 2000 mg de suplemento/kg de ração incrementa a taxa de crescimento de tilápias do Nilo criadas em sistema de tanques-rede e que o modelo de curvas exponenciais pode ser usado para comparar a eficiência de diferentes dietas em estudos de nutrição de peixes. / Abstract: The aim of this study was to evaluate the exponential growth model applicability to study feed supplementation efficiency with mannan oligosaccharide and 'beta'-glucan in Nile tilapia raised in net cage. The trial was carried out in a cage fish farm, at Zacarias city, SP. Juveniles tilapia (initial weigh 25,4 ± 2,04 g) were distributed in 12 cages (2 x 2 x 1,5 m), with 6 m3 volume and stock density of 2500 fish per cage. To evaluate the exponential growth model, a randomized sample of 5 % fish was collected for individual biometry in each experimental unit. The results show that 2000 mg of supplement/kg diet increase the growth ratio of Nile tilapias raised in net cage and the exponential growth model can be used to compare efficiency of different diets in nutrition studies. / Doutor

Glycosaminoglycans (GAGs) are sulfated polysaccharides that mediate a variety of extracellular interactions. Heparan sulfate (HS) is one of the most prominent GAGs on human cell surfaces. Both endogenous proteins, such as growth factors, and exogenous proteins, such as pathogen surface proteins, recognize and bind GAGs to gain access to human cells. Oligosaccharides and other structural analogs of HS and GAGs have been evaluated for a variety of therapeutic targets including angiogenesis and infectious diseases. Development of compounds to block HS-protein interactions has primarily focused on optimizing the degree and orientation of anionic substituents on a scaffold, to mimic HS structure, but their utility is diminished by their large size and non-specific interactions with many proteins. To overcome these limitations, it has been demonstrated that replacing N-sulfo groups on heparin with non-anionic N-arylacyl groups increased affinity and selectivity for binding different heparin-binding proteins. However, the heparin-derived compounds in that work were heterogeneous polysaccharides. Strategies to obtain small, structurally-defined and lower charge ligands are needed to ultimately obtain specific bind-and-block antagonists of HS-binding proteins. This study addresses these challenges by synthesizing N-arylacyl O-sulfonated aminoglycosides as small molecule, structurally-defined ligands to identify novel structures that selectively bind to HS-binding proteins. This study details development of new HPLC and LC-MS methods to separate, characterize, and purify amphiphilic oligosaccharides. The development of these methods enabled the synthesis of a panel of N-arylacyl O-sulfonated aminoglycosides. The compounds in this panel were screened for affinity and selectivity in binding with HS-binding proteins. This work demonstrates for the first time the selective binding of small amphiphilic oligosaccharides with HS-binding proteins. Significantly, individual compounds demonstrate heparin-like affinity for binding with select HS-binding proteins. Structural differences between the N-arylacyl O-sulfonated aminoglycosides, including changing the aminoglycoside core or the structure of the N-arylacyl moiety, are shown to impart specificity for these compounds to selectively bind different HS-binding proteins.

Le but de cette thèse est de concevoir une puce à sucres, compatible avec un système optique d'imagerie en résonance des plasmons de surface (SPRi), afin d'analyser simultanément de multiples interactions protéine/oligosaccharide en temps réel. La réalisation d'un système modèle, ayant comme sucre sonde, l'héparine, est proposée. La modification du sucre par un pyrrole permet de le déposer sur une surface d'or par électrocopolymérisation. Cette chimie nécessite la construction de molécules « pyrrole - bras espaceurs » compatibles avec les propriétés des sucres utilisés. La puce utilisable en SPRi est ensuite fabriquée par électrocopolymérisations successives. Ces plots formés peuvent être caractérisés par MEB et par AFM. Des expériences préliminaires utilisant des traceurs fluorescents ont permis de valider le système ainsi que la chimie proposée ; la fluorescence observée est spécifique de l'interaction biologique grâce à la présence de négatifs. Les études d'interactions biologiques suivies par SPRi ont alors été réalisées ; la sensibilité de l'interaction est confirmée. Grâce à l'acquisition en temps réel des interactions, les cinétiques d'association et de dissociation du complexe oligosaccharide/protéine sont observées puis optimisées. De plus, les puces fabriquées sont régénérables mais aussi réutilisables sur plusieurs mois, ce qui permet l'étude des paramètres chimiques et biologiques. Cette approche est appliquée finalement à plusieurs problématiques biologiques.

名古屋大学博士学位論文 学位の種類 : 博士(医学)(論文) 学位授与年月日:平成9年2月28日 森脇崇之氏の博士論文として提出された

Les virus influenza provoquent chaque année la grippe saisonnière qui peut toucher 5 à 15 % de la population. Les médicaments antiviraux sont un moyen important complémentaire à la vaccination pour le traitement et la prévention de la grippe. Actuellement, deux classes d'antiviraux ont été approuvées, l'une pour inhiber l'étape de décapsidation (l'inhibiteur du canal ionique M2), et l'autre pour empêcher la libération de néo-virions (l'inhibiteur de la neuraminidase). Cependant, de plus en plus de virus sont nativement résistants aux inhibiteurs de la protéine M2. Des virus résistants aux inhibiteurs de la neuraminidase ont également circulé durant les hivers 2008 - 2009. Le développement de nouveaux médicaments afin de substituer ou de compléter ces inhibiteurs est donc crucial dans la lutte contre les virus de la grippe. L'accent mis ces dernières années sur l'activité biologique des sucres (oligosaccharides/polysaccharides) montre une voie pour l'étude de l'activité antivirale d'une des plus importantes biosources. Dans le but d'évaluer le potentiel antigrippal des molécules dérivées de sucres, nous avons effectué un criblage à partir d'une bibliothèque de 245 composés de polysaccharides et d'oligosaccharides, dont la plupart proviennent d'algues et de végétaux supérieurs. Plusieurs molécules actives réparties dans différentes familles de sucres ont été mises en évidence. Parmi les candidats d'intérêt, l'oligosaccharide sulfaté 152, appartenant à la famille des arabinogalactanes de l'espèce Codium fragile, a présenté une activité inhibitrice vis-à-vis des deux virus influenza de type A et de type B in vitro. Le mécanisme d'action de cet oligosaccharide a été caractérisé. Il montre que les deux glycoprotéines de surface, l'hémagglutinine et la neuraminidase, sont les cibles virales de cette molécule

Peptidoglycan, the major component of the bacterial cell wall, is essential for cell viability. Several important antibiotics disrupt peptidoglycan metabolism, including the β-lactams and vancomycin. There are several bacterial enzymes involved in peptidoglycan metabolism that are not yet the target of antibiotics, such as the lytic transglycosylases (LTs). Relatively little experimental characterization has been done on LTs, due largely to the difficulties of working with insoluble, heterogeneous, and highly variable peptidoglycan. This research develops a method for the generation of a soluble, homogeneous oligosaccharide substrate that can be used to study LTs. The approach taken was based on the enzymatic degradation of peptidoglycan into fragments of a specific nature, and their separation by HPLC. This work identifies the challenges associated with this approach, and discusses the potential flaws in the 'top-down' generation of a soluble substrate. / This thesis was typeset with LaTeX using Minion Pro and Myriad Pro typefaces.

No description available.

Heparan sulfate (HS) belongs to the glycosaminoglycan family of polysaccharides and is found attached to protein cores on cell surfaces and in the extracellular matrix. The HS backbone consists of alternating hexuronic acid and glucosamine units and undergoes a number of modification reactions creating HS chains with alternating highly and low modified domains, where high degree of modification correlates with high negative charge. Fibroblast growth factors (FGFs) and their receptors (FRs) both bind to HS, which affect formation of the FGF–FR complexes on the cell surfaces. Activated FRs can trigger several intracellular signaling pathways leading thereby to diverse cellular responses. Work presented in this thesis focuses on the effect of HS and its structures on FGF–FR complex formation and FGF-induced signaling. Studies with short, highly modified oligosaccharides and FGF1 and 2 combined with FR1c, 2c, 3c or 4 showed a correlation between the overall degree of modification and amount/stability of FGF–FR complexes. Our findings imply that several HS structures, differently modified but with the same negative charge density are equal in their ability to support complex formation. Co-application of oligosaccharides with FGF2 to HS-deficient cells and investigation of the thereby induced cell signaling confirmed our findings with a cell-free system. The oligosaccharide with the highest modification degree displayed the biggest impact on cell signaling, which was FGF2 concentration dependent. Studies with long HS polysaccharides with preserved high and low modified domains suggest that the proportion between these two types of domains and also the structure of the low modified domains are of importance for the FGF–HS–FR complex formation and cell activation capacity. This work illuminates several aspects in how HS structure influences the interplay between FGFs and FRs and contributes to the understanding of what factors affect a cell’s response following FGF stimulation.

München, Techn. Univ., Diss., 2000.